Leaders in Pediatric Neuromuscular Research
Dr. Zaidman serves as the principal investigator on more than 15 clinical research trials in pediatric neuromuscular disorders. He supervises a team of six researchers who are helping develop innovative treatments. Based on his experience in these clinical trials, Dr. Zaidman and the care team are aggressive and early adopters of the latest advanced therapies for neuromuscular disorders, including gene modifying treatments for spinal muscular atrophy and Duchenne Muscular Dystrophy.
We are currently participating in several clinical research trials for children with neuromuscular disorders. Our support team can coordinate with your insurance company to support all potential diagnostic and therapy plans.
Our team members have been key participants in researching and developing innovative therapeutics, that achieved FDA approval.
